How Microplastics Affect Human Health: Evidence from Peer-Reviewed Research

Cardiovascular system

A prospective, multicentre study published in the New England Journal of Medicinein March 2024 by Marfella and colleagues examined 304 patients undergoing carotid endarterectomy. Microplastics and nanoplastics were detected in arterial plaque specimens using pyrolysis–gas chromatography–mass spectrometry, stable isotope analysis, and electron microscopy. Patients in whom microplastics were detected within the plaque had a significantly higher risk of the composite primary endpoint of myocardial infarction, stroke, or death from any cause at 34 months of follow-up (hazard ratio 4.53; 95% CI 2.00–10.27; p<0.001)².

Important caveat: Several letters to the editor raised questions about potential intraoperative contamination of samples in the Marfella study. The authors responded to these concerns. Readers should be aware this is observational evidence; confounding and contamination questions remain open.

The reproductive system

In men: A 2024 study by Hu and colleagues published in Toxicological Sciences detected microplastics in every human and canine testicular sample examined, identifying polyethylene, polyvinyl chloride, and PET as the most prevalent polymers⁷. A separate multi-site study published in eBioMedicine (2024) examining 113 male participants across three Chinese provinces found associations between higher microplastic concentrations in semen and reduced sperm progressive motility⁸.

In women: Ragusa and colleagues (2021) published the first detection of microplastics in the human placenta, using Raman microspectroscopy to examine six placentas from women with uneventful pregnancies. Particles were found in four placentas on both the maternal and fetal sides³. The same group published the first detection of microplastics in human breast milk in 2022, finding them in 26 of 34 samples tested⁴.

The gut and digestive system

Thornton Hampton and colleagues, in a 2022 review published in Microplastics and Nanoplastics, assessed the body of evidence for health impacts across organ systems. For digestive outcomes (immunosuppression in the gut), the review rated the overall body of evidence as "high" using the Navigation Guide systematic review method — though this was based primarily on animal evidence⁹.

Animal studies have shown that microplastic exposure can inflame intestinal tissue, disrupt the intestinal mucosal barrier, and alter gut microbiome composition. Human observational associations with colorectal outcomes have been reported but require further study¹².

The brain and nervous system

Microplastics have been detected in human brain tissue in post-mortem studies, with concentrations found to exceed those in other organs from the same donors — a finding that raises questions about preferential accumulation.

A 2026 study published in Frontiers in Cell and Developmental Biology by Wang and colleagues reviewed evidence that microplastic exposure activates cellular ageing pathways (p53, p21, p16) in neurons and may accelerate age-related neurodegeneration¹³. Animal studies confirm that nanoplastics can cross the blood-brain barrier and induce neuroinflammation. Direct causal evidence in living humans is not yet established.

For full treatment, see: microplastics, brain & dementia →

Hormones and the endocrine system

Plastics contain chemical additives — including phthalates, bisphenols (BPA, BPS), and polybrominated diphenyl ethers — classified as endocrine disruptors. A 2021 review by Kannan and Vimalkumar in Frontiers in Endocrinology documented the evidence for plastics-associated chemicals as "obesogens" — compounds that mechanistically promote fat storage and metabolic disruption¹⁸. A 2020 review by Campanale and colleagues catalogued the endocrine-disrupting potential of common plastic additives in detail¹0.

What we don't yet know

The scientific community emphasises several open questions¹⁵:

• Dose-response: What level of human microplastic exposure triggers measurable harm? No safe threshold has been identified.
• Particle vs chemical effects: Is harm primarily from the particles, from chemicals they carry, or both?
• Long-term accumulation: Do microplastics accumulate indefinitely, or does clearance occur?
• Individual variation: What factors determine differential body burden?

Vethaak and Legler, writing in Science in 2021, concluded: "The evidence for adverse health effects from microplastics is growing but still incomplete... urgent investment in research is needed."¹⁵

FAQ

Q: Should I be worried about microplastics right now?
A: The precautionary principle applies. The evidence — particularly from the cardiovascular² and reproductive⁷⁸ studies — is serious enough to warrant practical steps to reduce exposure. It is not strong enough to conclude that average current exposure is causing widespread acute harm in the general population.

Q: Are children more at risk?
A: Children are likely more vulnerable due to higher food and air intake relative to body weight, greater sensitivity of developing systems to endocrine disruption, and longer time horizons for accumulation. In-utero exposure via the placenta is now confirmed³.